Navigation Links
fiteBac™ SkinCare, LLC Participates in OSAP Symposium on Infection Control
Date:6/27/2012

Marietta, GA (PRWEB) June 27, 2012

OSAP is an annual conference that focuses on issues that impact infection prevention in the delivery of oral healthcare. Both industry experts and companies presented information on the cutting edge developments in science and technology in infection control. fiteBac SkinCare Germicidal Hand Softening Gel was presented to address critical issues faced in the arena of hand sanitizing.

fiteBac was extremely well received at the OSAP symposium. Attendees and educators were presented the skin-friendly, alcohol-free, water-free hand sanitizer at the conference. At the booth, the sanitizer was placed on the hands of attendees, so they could experience the “wow” feeling of the product. One-ounce samples were given at the convention for attendees to take home. “It is the intent of fiteBac to help make a difference in infection prevention in the delivery of dental care. It was our pleasure to attend the seminar, and we look forward to returning in 2012,” commented Kirk Kimmerling, DDS and CEO of fiteBac SkinCare, LLC.

fiteBac SkinCare, LLC attended the symposium to share with dental educators the many benefits of fiteBac’s technology. “It was an excellent opportunity to attend a conference with like-minded people interested in infection prevention. Collaboration of efforts is very powerful when tackling issues on safety, asepsis and prevention in the delivery of oral care,” Dr. Kimmerling noted. “Sharing information on science and products helps create the best possible outcomes and we are happy to participate in the solution. We believe our skin-friendly hand softening gel will help those practicing healthcare to achieve a higher level commitment to excellence in hand hygiene.”

OSAP was founded in 1984 helping like-minded people forge forward issues of infection prevention and policy development in dentistry. The overall goal of the group is to allow people to obtain safe dental care without transmitting infection. Over 20 speakers addressed the convention dispersing information and sharing developments in the field. fiteBac SkinCare LLC enjoyed a healthy reception with its futuristic hand sanitizing product.    

About fiteBac™ SkinCare, LLC and KHG: fiteBac SkinCare, LLC is a subsidiary company of Kimmerling Holdings Group, LLC (“KHG”), a Georgia-based biotech company that has developed an antimicrobial platform intellectual property technology. KHG was founded in 2009 by a family dentist in Marietta, GA, Kirk Kimmerling, DDS and Dan Kearney. For More information on the dental practice of Dr. Kimmerling, click here. The two set out to create products to “change the world, one product at a time.” Kirk and Dan first targeted bacterial issues in dentistry, knowing that solving those problems would lead to dramatic improvements in oral health, and more importantly, systemic bodily health. They engaged a team of highly accomplished chemists and scientists retired from Fortune 500 companies and researchers from major universities. In doing so, KHG has developed technology with several patents pending that has application well beyond dental materials, and has exciting potential in medical, plastic, composite, coating and other applications that are in various stages of development, some close to commercialization. fiteBac™ SkinCare Hand Softening Gel is the first product to be released under the fiteBac brand name.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9640309.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kessler Foundation scientists present cognitive research findings at MS dual symposium
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. Triple negative breast cancer symposium highlights current advances
4. CWRU nurse researcher surveys infection control practices for home patients
5. Sun exposure and cutaneous HPV infection found synergistic in skin cancers, Moffitt says
6. A non-antibiotic approach for treating urinary tract infections
7. Discovery helps mice beat urinary tract infections
8. HIV superinfection in Uganda may be more common than previously thought, study finds
9. Ritual in Some Jewish Circumcisions Raises Risk of Herpes Infection: Report
10. Acne Medication May Raise Risk of Eye Infections
11. Hepatitis B Infection Rates in U.S. Higher Than Thought
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites ... defects research related to Zika virus during pregnancy, as well as other prenatal ... important science. , The Teratology Society is an international and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... 25, 2017 , ... There is no better place in South Florida to ... in the May issue of Consumer Reports focused on heart health. , The ... during and after coronary bypass and aortic valve replacement procedures. , Consumer Reports ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
(Date:4/24/2017)... ... ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian Award. The ... conference, on April 23 in Orlando, FL. , “I am proud that ATA is ... poor and underserved in other parts of the world,” said Jonathan Linkous, CEO of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
Breaking Medicine Technology: